Publications by authors named "D Ballinari"

Claim this Profile
H
How to gauge investor behavior? A comparison of online investor sentiment measures.
Daniele Ballinari, Simon Behrendt

Digit Finance· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
Paola Magnaghi, Barbara Salom, Liviana Cozzi, Nadia Amboldi, Dario Ballinari

Mol Cancer Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.
Roberta Bosotti, Paola Magnaghi, Sebastiano Di Bella, Liviana Cozzi, Carlo Cusi, Dario Ballinari

Sci Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications.
Elena Ardini, Maria Menichincheri, Patrizia Banfi, Roberta Bosotti, Cristina De Ponti, Dario Ballinari

Mol Cancer Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers.
Michele Modugno, Patrizia Banfi, Fabio Gasparri, Robert Borzilleri, Percy Carter, Dario Ballinari

Exp Cell Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis